Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | USP2 | O75604 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18342537 | 0.95 | MAPT (0.49) | ALDH1A1USP2MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL28678561 | 0.84 | USP2 (0.38) | ALDH1A1USP2MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL27545815 | 0.83 | TSHR (0.41) | ALDH1A1HPGDPLA2G2CTSHR | |
| SCHEMBL111270 | 0.81 | FAAH (0.39) | ALDH1A1FAAHTSHR | |
| SCHEMBL15645172 | 0.81 | FAAH (0.39) | ALDH1A1FAAHTSHR | |
| SCHEMBL15689848 | 0.81 | FAAH (0.39) | ALDH1A1FAAHTSHR | |
| SCHEMBL16177782 | 0.80 | FAAH (0.41) | MAPTFAAHTSHR | |
| SCHEMBL8152281 | 0.80 | FAAH (0.41) | MAPTFAAHTSHR | |
| SCHEMBL6503353 | 0.80 | FAAH (0.41) | MAPTFAAHTSHR | |
| SCHEMBL28416992 | 0.80 | FAAH (0.41) | MAPTFAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-54055511-A | — | — | None | — | — | JP | disclosed |
| EP-4056604-B1 | METHOD FOR PRODUCING COPOLYMER OF 1,3,7-OCTATRIENE AND STYRENE | KURARAY CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-3564280-B1 | COPOLYMER OF 1, 3, 7-OCTATRIENE AND STYRENE AND HYDRIDE THEREOF | KURARAY CO (JP) | 2023-07-26 | — | — | EP | disclosed |
| EP-3586961-B1 | METHOD FOR MANUFACTURING CATALYST LIQUID | KURARAY CO (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-11628430-B2 | Method for manufacturing catalyst liquid | KURARAY CO., LTD. (JP) | 2023-04-18 | — | — | US | disclosed |
| EP-4163311-A1 | COPOLYMER OF 1,3,7-OCTATRIENE AND ISOPRENE, HYDRIDE THEREOF, AND METHOD FOR PRODUCING SAID COPOLYMER | Kuraray Co., Ltd. (JP) | 2023-04-12 | — | — | EP | disclosed |
| EP-4163312-A1 | COPOLYMER OF 1,3,7-OCTATRIENE AND ISOPRENE, HYDRIDE THEREOF, AND METHOD FOR PRODUCING SAID COPOLYMER | Kuraray Co., Ltd. (JP) | 2023-04-12 | — | — | EP | disclosed |
| EP-3564274-B1 | 1, 3, 7-OCTATRIENE POLYMER, HYDRIDE THEREOF, AND METHOD FOR PRODUCING SAID POLYMER | KURARAY CO (JP) | 2022-12-28 | — | — | EP | disclosed |
| CN-110290872-B | Method for producing catalyst liquid | 株式会社可乐丽 | 2022-10-18 | — | — | CN | disclosed |
| EP-4056604-A1 | METHOD FOR PRODUCING COPOLYMER OF 1,3,7-OCTATRIENE AND STYRENE | Kuraray Co., Ltd. (JP) | 2022-09-14 | — | — | EP | disclosed |
| EP-0704417-A2 | Process for producing octadienes | KURARAY CO., LTD. (JP) | 1996-04-03 | — | — | EP | disclosed |
| EP-0296550-B1 | Phosphonium salts and processes for production of and uses for the same | KURARAY CO (JP) | 1993-12-29 | — | — | EP | disclosed |
| US-5118837-A | Reaction of olefinic double bond in presence of other, less reactive olefinic double bonds; modified ruthenium catalyst with trivalent phosphorus or nitrogen or divalent sulfur compound | GIVAUDAN CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| US-5100854-A | Telomerization catalysts | KURARAY CO., LTD. (JP) | 1992-03-31 | — | — | US | disclosed |
| US-4992609-A | Telomerization catalysts | KURARAY CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| US-4927960-A | TELOMERIZATION CATALYST | KURARAY COMPANY, LTD. (JP) | 1990-05-22 | — | — | US | disclosed |
| EP-0296550-A2 | Phosphonium salts and processes for production of and uses for the same | KURARAY CO., LTD. (JP) | 1988-12-28 | — | — | EP | disclosed |
| US-4181683-A | INTERMEDIATES FOR PERFUMES AND ESTROGEN-DERIVATIVE DRUGS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| JP-S5455511-A | 1,7-OCTADIENE-3-ONE AND ITS PREPARATION | MITSUBISHI PETROCHEM CO LTD | 1979-05-02 | — | — | JP | disclosed |
| US-3981907-A | Method of producing highly unsaturated compounds by reacting 1,3-conjugated diene compounds with derivatives of dimers of butadienes and products | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11628430-B2 | Method for manufacturing catalyst liquid | OSGEP, PNP, ALK | ALDH1A1 1351/4885USP2 2735/4885MAPT 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.